These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 37233715)

  • 1. The Interplay between Gut Microbiota and Oral Medications and Its Impact on Advancing Precision Medicine.
    Mousa S; Sarfraz M; Mousa WK
    Metabolites; 2023 May; 13(5):. PubMed ID: 37233715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiome: The Interplay of an "Invisible Organ" with Herbal Medicine and Its Derived Compounds in Chronic Metabolic Disorders.
    Lim DW; Wang JH
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?
    Chen F; Wen Q; Jiang J; Li HL; Tan YF; Li YH; Zeng NK
    J Ethnopharmacol; 2016 Feb; 179():253-64. PubMed ID: 26723469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era.
    Wang S; Ju D; Zeng X
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplays between drugs and the gut microbiome.
    Wan Y; Zuo T
    Gastroenterol Rep (Oxf); 2022; 10():goac009. PubMed ID: 35401987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host-microbiome metabolism of a plant toxin in bees.
    Motta EVS; Gage A; Smith TE; Blake KJ; Kwong WK; Riddington IM; Moran N
    Elife; 2022 Dec; 11():. PubMed ID: 36472498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the human gut microbiome to better decipher drug liability: A once-forgotten organ takes center stage.
    Cai J; Auster A; Cho S; Lai Z
    J Adv Res; 2023 Oct; 52():171-201. PubMed ID: 37419381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.
    Khalsa J; Duffy LC; Riscuta G; Starke-Reed P; Hubbard VS
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):176-185. PubMed ID: 28263462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential impact of gut microbiota on your health:Current status and future challenges.
    Sirisinha S
    Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes.
    Taguer M; Maurice CF
    Clin Pharmacol Ther; 2016 Jun; 99(6):588-99. PubMed ID: 26950037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the role of gut microbiota in advancing personalized medicine.
    Huang G; Khan R; Zheng Y; Lee PC; Li Q; Khan I
    Front Microbiol; 2023; 14():1274925. PubMed ID: 38098666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs.
    Feng W; Liu J; Ao H; Yue S; Peng C
    Theranostics; 2020; 10(24):11278-11301. PubMed ID: 33042283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota medicine: towards clinical revolution.
    Gebrayel P; Nicco C; Al Khodor S; Bilinski J; Caselli E; Comelli EM; Egert M; Giaroni C; Karpinski TM; Loniewski I; Mulak A; Reygner J; Samczuk P; Serino M; Sikora M; Terranegra A; Ufnal M; Villeger R; Pichon C; Konturek P; Edeas M
    J Transl Med; 2022 Mar; 20(1):111. PubMed ID: 35255932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of gut microbiota on drug metabolism and toxicity.
    Li H; He J; Jia W
    Expert Opin Drug Metab Toxicol; 2016; 12(1):31-40. PubMed ID: 26569070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of Intestinal Microbiota with Medications.
    Liu M; Xu J; Jin Q; Li Y
    Curr Drug Metab; 2023; 24(8):554-567. PubMed ID: 37073652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacomicrobiomics: a novel route towards personalized medicine?
    Doestzada M; Vila AV; Zhernakova A; Koonen DPY; Weersma RK; Touw DJ; Kuipers F; Wijmenga C; Fu J
    Protein Cell; 2018 May; 9(5):432-445. PubMed ID: 29705929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic effect of gut microbiota on drugs.
    Xie Y; Hu F; Xiang D; Lu H; Li W; Zhao A; Huang L; Wang R
    Drug Metab Rev; 2020 Feb; 52(1):139-156. PubMed ID: 32116054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs.
    Noh K; Kang YR; Nepal MR; Shakya R; Kang MJ; Kang W; Lee S; Jeong HG; Jeong TC
    Arch Pharm Res; 2017 Dec; 40(12):1345-1355. PubMed ID: 29181640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NSAID-Gut Microbiota Interactions.
    Maseda D; Ricciotti E
    Front Pharmacol; 2020; 11():1153. PubMed ID: 32848762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Time-Restricted Feeding/Eating: A Targeted Biomarker and Approach in Precision Nutrition.
    Zeb F; Osaili T; Obaid RS; Naja F; Radwan H; Cheikh Ismail L; Hasan H; Hashim M; Alam I; Sehar B; Faris ME
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.